Loading chart…
CLOSED
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic therapeutic areas.
Ipca Laboratories Limited (IPCALAB) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The IPCALAB share price is ₹1,970.50 (+1.67% today), with a market capitalisation of ₹500B and a price-to-earnings (P/E) ratio of 35.6. MarketRipple tracks the IPCALAB investment thesis, the ripple-chain impact of market events on Ipca Laboratories Limited, and the Healthcare sector outlook.
Open
₹1,931.00
High
₹1,991.70
Low
₹1,928.30
Prev. Close
₹1,938.20
52W High
₹2,038.00
52W Low
₹1,293.90
Day range
₹1,928.30–₹1,991.70
52-week range
₹1,293.90–₹2,038.00
Volume
152K
P/E
35.6
ROE
15.6%
D/E
0.10
Margin
13.4%
Ipca Laboratories Limited (NSE: IPCALAB) is currently trading at ₹1,970.50 (+1.67%).
Ipca Laboratories Limited's market capitalization is ₹500B.
Ipca Laboratories Limited's price-to-earnings (P/E) ratio is 35.6.
Ipca Laboratories Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Ipca Laboratories Limited currently reads positive, based on 18 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.